Portal Vein Thrombosis

American Journal of Medicine

Volumn 123, Issue 2, 2010, Pages 111-119

  Parikh, Sameer ^a   Shah, Riddhi ^a   Kapoor, Prashant ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Anticoagulation; Cirrhosis; Coagulopathy; Myeloproliferative diseases

Indexed keywords

ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT;

ACUTE DISEASE; ANTICOAGULANT THERAPY; BLEEDING; CHRONIC DISEASE; COMORBIDITY; DOPPLER ECHOGRAPHY; DRUG CONTRAINDICATION; ESOPHAGUS VARICES BLEEDING; FIBRINOLYTIC THERAPY; HUMAN; INTESTINE INFARCTION; INTESTINE ISCHEMIA; LIVER CIRRHOSIS; PORTAL HYPERTENSION; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; REVIEW; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT;

ANTICOAGULANTS; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; PORTAL VEIN; VENOUS THROMBOSIS;

EID: 74549150126     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2009.05.023     Document Type: Review

References (40)

1. Okuda K., Ohnishi K., Kimura K., et al. Incidence of portal vein thrombosis in liver cirrhosis. An angiographic study in 708 patients. Gastroenterology 89 (1985) 279-286
2. Amitrano L., Guardascione M.A., Brancaccio V., et al. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol. 40 (2004) 736-741
3. Valla D.C., Condat B., and Lebrec D. Spectrum of portal vein thrombosis in the West. J Gastroenterol Hepatol. 17 Suppl 3 (2002) S224-S227
4. Sarin S.K., Sollano J.D., Chawla Y.K., et al. Consensus on extra-hepatic portal vein obstruction. Liver Int. 26 (2006) 512-519
5. Amitrano L., Brancaccio V., Guardascione M.A., et al. Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis. Hepatology 31 (2000) 345-348
6. Mangia A., Villani M.R., Cappucci G., et al. Causes of portal venous thrombosis in cirrhotic patients: the role of genetic and acquired factors. Eur J Gastroenterol Hepatol. 17 (2005) 745-751
7. Witte C.L., Brewer M.L., Witte M.H., and Pond G.B. Protean manifestations of pylethrombosis. A review of thirty-four patients. Ann Surg. 202 (1985) 191-202
8. Webb L.J., and Sherlock S. The aetiology, presentation and natural history of extra-hepatic portal venous obstruction. Q J Med. 48 (1979) 627-639
9. Sheen C.L., Lamparelli H., Milne A., et al. Clinical features, diagnosis and outcome of acute portal vein thrombosis. QJM 93 (2000) 531-534
10. Ni Y.H., Wang N.C., Peng M.Y., et al. Bacteroides fragilis bacteremia associated with portal vein and superior mesentery vein thrombosis secondary to antithrombin III and protein C deficiency: a case report. J Microbiol Immun Infect. 35 (2002) 255-258
11. Abdelrazeq A.S., Dwaik M.A., Aldoori M.I., et al. Laparoscopy-associated portal vein thrombosis: description of an evolving clinical syndrome. J Laparoendosc Adv Surg Tech A 16 (2006) 9-14
12. Poultsides G.A., Lewis W.C., Feld R., et al. Portal vein thrombosis after laparoscopic colectomy: thrombolytic therapy via the superior mesenteric vein. Am Surg. 71 (2005) 856-860
13. Chait Y., Condat B., Cazals-Hatem D., et al. Relevance of the criteria commonly used to diagnose myeloproliferative disorder in patients with splanchnic vein thrombosis. Br J Haematol. 129 (2005) 553-560
14. Kralovics R., Passamonti F., Buser A.S., et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med. 352 (2005) 1779-1790
15. Primignani M., Barosi G., Bergamaschi G., et al. Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis. Hepatology 44 (2006) 1528-1534
16. Kiladjian J.J., Cervantes F., Leebeek F.W., et al. The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases. Blood 111 (2008) 4922-4929
17. Gertsch P., Matthews J., Lerut J., et al. Acute thrombosis of the splanchnic veins. Arch Surg. 128 (1993) 341-345
18. Cohen J., Edelman R.R., and Chopra S. Portal vein thrombosis: a review. Am J Med. 92 (1992) 173-182
19. Chandra R., Kapoor D., Tharakan A., et al. Portal biliopathy. J Gastroenterol Hepatol. 16 (2001) 1086-1092
20. Kearon C., Kahn S.R., Agnelli G., et al. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133 6 Suppl (2008) 454S-545S
21. Haddad M.C., Clark D.C., Sharif H.S., et al. MR, CT, and ultrasonography of splanchnic venous thrombosis. Gastrointest Radiol. 17 (1992) 34-40
22. Ueno N., Sasaki A., Tomiyama T., et al. Color Doppler ultrasonography in the diagnosis of cavernous transformation of the portal vein. J Clin Ultrasound 25 (1997) 227-233
23. Lai L., and Brugge W.R. Endoscopic ultrasound is a sensitive and specific test to diagnose portal venous system thrombosis (PVST). Am J Gastroenterol. 99 (2004) 40-44
24. Fimognari F.L., and Violi F. Portal vein thrombosis in liver cirrhosis. Intern Emerg Med. 3 (2008) 213-218
25. de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 43 (2005) 167-176
26. Sogaard K.K., Astrup L.B., Vilstrup H., and Gronbaek H. Portal vein thrombosis; risk factors, clinical presentation and treatment. BMC Gastroenterol. 7 (2007) 34
27. Condat B., Pessione F., Helene Denninger M., et al. Recent portal or mesenteric venous thrombosis: increased recognition and frequent recanalization on anticoagulant therapy. Hepatology 32 (2000) 466-470
28. Plessier A., Murad S.D., Hernandez-Guerra M., et al. A prospective multicentric follow-up study on 105 patients with acute portal vein thrombosis (PVT): results from the European Network for Vascular Disorders of the LIver (EN-Vie). Hepatology 46 (2007) 310A
29. Baril N., Wren S., Radin R., et al. The role of anticoagulation in pylephlebitis. Am J Surg 172 (1996) 449-452 discussion 52-53
30. Semiz-Oysu A., Keussen I., and Cwikiel W. Interventional radiological management of prehepatic obstruction of [corrected] the splanchnic venous system. Cardiovasc Intervent Radiol. 30 (2007) 688-695
31. Hollingshead M., Burke C.T., Mauro M.A., et al. Transcatheter thrombolytic therapy for acute mesenteric and portal vein thrombosis. J Vasc Interv Radiol. 16 (2005) 651-661
32. Malkowski P., Pawlak J., Michalowicz B., et al. Thrombolytic treatment of portal thrombosis. Hepatogastroenterology 50 (2003) 2098-2100
33. Ferro C., Rossi U.G., Bovio G., et al. Transjugular intrahepatic portosystemic shunt, mechanical aspiration thrombectomy, and direct thrombolysis in the treatment of acute portal and superior mesenteric vein thrombosis. Cardiovascular Intervent Radiol. 30 (2007) 1070-1074
34. Orr D.W., Harrison P.M., Devlin J., et al. Chronic mesenteric venous thrombosis: evaluation and determinants of survival during long-term follow-up. Clin Gastroenterol Hepatol. 5 (2007) 80-86
35. Condat B., Pessione F., Hillaire S., et al. Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy. Gastroenterology 120 (2001) 490-497
36. Spaander M.C., Murad S.D., van Buuren H.R., et al. Endoscopic treatment of esophagogastric variceal bleeding in patients with noncirrhotic extrahepatic portal vein thrombosis: a long-term follow-up study. Gastrointest Endosc. 67 (2008) 821-827
37. Valla D.C., and Condat B. Portal vein thrombosis in adults: pathophysiology, pathogenesis and management. J Hepatol. 32 (2000) 865-871
38. Janssen H.L., Wijnhoud A., Haagsma E.B., et al. Extrahepatic portal vein thrombosis: aetiology and determinants of survival. Gut 49 (2001) 720-724
39. Vibert E., Azoulay D., Aloia T., et al. Therapeutic strategies in symptomatic portal biliopathy. Ann Surg. 246 (2007) 97-104
40. Amitrano L., Guardascione M.A., Scaglione M., et al. Prognostic factors in noncirrhotic patients with splanchnic vein thromboses. Am J Gastroenterol. 102 (2007) 2464-2470